APA (7th ed.) Citation

H, L., YC, O., HC, F., SW, H., CH, W., & CC, C. (2025). Molecular subtyping and the 2023 FIGO staging in endometrial cancer: Redefining adjuvant therapy. Taiwanese journal of obstetrics & gynecology, 64(4), 616. https://doi.org/10.1016/j.tjog.2025.04.007

Chicago Style (17th ed.) Citation

H, Lin, Ou YC, Fu HC, Huang SW, Wu CH, and Changchien CC. "Molecular Subtyping and the 2023 FIGO Staging in Endometrial Cancer: Redefining Adjuvant Therapy." Taiwanese Journal of Obstetrics & Gynecology 64, no. 4 (2025): 616. https://doi.org/10.1016/j.tjog.2025.04.007.

MLA (9th ed.) Citation

H, Lin, et al. "Molecular Subtyping and the 2023 FIGO Staging in Endometrial Cancer: Redefining Adjuvant Therapy." Taiwanese Journal of Obstetrics & Gynecology, vol. 64, no. 4, 2025, p. 616, https://doi.org/10.1016/j.tjog.2025.04.007.